title: [Anti-arrhythmic effect of cordaron in patients with unstable stenocardia and myocardial infarction].
abstract: Antiarrhythmic effect of cordaron in patients with unstable stenocardia (34) and transmural myocardial infarction (39) has been studied in various dose regimens. A dose of 400-600 mg/day was significantly effective in unstable angina pectoris, while in myocardial infarction a 600 mg/day dose failed to attenuate arrhythmia, i.e. the number and frequency of extra-systoles reduced insignificantly. In subacute disease a 200 mg/day cordaron could not prevent an increment of arrhythmia showing inadequacy of a standard scheme of the drug administration.
authors: T E
authors: TE
authors: Dobrotvorskaia
authors: F M
authors: FM
authors: Mustafaev
authors: T I
authors: TI
authors: Abdullaeva
authors: N L
authors: NL
authors: Matsueva
mesh_terms: D000328:Adult; D000368:Aged; D000638:Amiodarone / Q000008:administration & dosage / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000150:complications*; D000789:Angina, Unstable / Q000150:complications*; D005117:Cardiac Complexes, Premature / Q000188:drug therapy* / Q000209:etiology; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications*
chemical_list: D000638:Amiodarone
vernacular_title: Antiaritmicheskiĭ éffekt kordarona u bo'lnykh s nestabi'lnoĭ stenokardieĭ i infarktom miokarda.